Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bjartmar, C.
Right arrow Articles by Trapp, B. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bjartmar, C.
Right arrow Articles by Trapp, B. D.
Related Collections
Right arrow MRI
Right arrow Multiple sclerosis
Neurology 2001;57:1248-1252
© 2001 American Academy of Neurology
Articles

Axonal loss in normal-appearing white matter in a patient with acute MS

C. Bjartmar, MD PhD;, R. P. Kinkel, MD, G. Kidd, PhD, R. A. Rudick, MD and B. D. Trapp, PhD

From the Department of Neurosciences, Lerner Research Institute (Drs. Bjartmar, Kidd, Rudick, and Trapp), Department of Neurology (Mellen Center) (Drs. Kinkel and Rudick), and the Center for Clinical Research (Dr. Rudick), Cleveland Clinic Foundation, OH.

Address correspondence and reprint requests to Dr. Bruce D. Trapp, Department of Neurosciences, Lerner Research Institute, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: trappb{at}ccf.org

Background: Brain imaging studies detect abnormalities in normal-appearing white matter in patients with MS. Objective: To investigate the histopathologic basis for these changes in autopsy tissue from a patient with MS with 9 months’ disease duration and a terminal brain stem lesion. Methods: The brain stem and spinal cord were analyzed ultrastructurally and immunocytochemically for axons, myelin, and activated microglia/macrophages. Results: Pathologic findings were consistent with a terminal inflammatory demyelinated lesion at the cervicomedullary junction. The ventral spinal cord column, containing descending tracts, exhibited 22% axonal loss at segment C7, but grossly normal immunostaining for myelin. Confocal and electron microscopy revealed myelin sheaths without axonal content and initial stages of myelin degradation by activated microglia/macrophages among intact myelinated axons. Axonal number and appearance was normal in ascending sensory tracts. Conclusions: These studies confirm axonal degeneration in the absence of myelin loss as one histopathologic correlate to abnormal MR findings in patients with MS.




This article has been cited by other articles:


Home page
 J. Neurol. Neurosurg. PsychiatryHome page
I I Kirov, V Patil, J S Babb, H Rusinek, J Herbert, and O Gonen
MR spectroscopy indicates diffuse multiple sclerosis activity during remission
J. Neurol. Neurosurg. Psychiatry, December 1, 2009; 80(12): 1330 - 1336.
[Abstract] [Full Text] [PDF]

Home page
 Cereb CortexHome page
S. Amadio, C. Montilli, R. Magliozzi, G. Bernardi, R. Reynolds, and C. Volonte
P2Y12 Receptor Protein in Cortical Gray Matter Lesions in Multiple Sclerosis
Cereb Cortex, September 26, 2009; (2009) bhp193v1.
[Abstract] [Full Text] [PDF]

Home page
 Mult SclerHome page
M Podbielska and E. Hogan
Molecular and immunogenic features of myelin lipids: incitants or modulators of multiple sclerosis?
Multiple Sclerosis, September 1, 2009; 15(9): 1011 - 1029.
[Abstract] [PDF]

Home page
 J. Neurosci.Home page
J. Das Sarma, L. C. Kenyon, S. T. Hingley, and K. S. Shindler
Mechanisms of Primary Axonal Damage in a Viral Model of Multiple Sclerosis
J. Neurosci., August 19, 2009; 29(33): 10272 - 10280.
[Abstract] [Full Text] [PDF]

Home page
 Mult SclerHome page
J Furby, T Hayton, D Altmann, R Brenner, J Chataway, K. Smith, D. Miller, and R Kapoor
Different white matter lesion characteristics correlate with distinct grey matter abnormalities on magnetic resonance imaging in secondary progressive multiple sclerosis
Multiple Sclerosis, June 1, 2009; 15(6): 687 - 694.
[Abstract] [PDF]

Home page
 Mult SclerHome page
G Tedeschi, D Dinacci, M Comerci, L Lavorgna, G Savettieri, A Quattrone, P Livrea, F Patti, V Brescia Morra, G Servillo, et al.
Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study
Multiple Sclerosis, February 1, 2009; 15(2): 204 - 211.
[Abstract] [PDF]

Home page
 IOVSHome page
X. Qi, L. Sun, A. S. Lewin, W. W. Hauswirth, and J. Guy
Long-term Suppression of Neurodegeneration in Chronic Experimental Optic Neuritis: Antioxidant Gene Therapy
Invest. Ophthalmol. Vis. Sci., December 1, 2007; 48(12): 5360 - 5370.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
H. Cheng, M. Laron, J. S. Schiffman, R. A. Tang, and L. J. Frishman
The Relationship between Visual Field and Retinal Nerve Fiber Layer Measurements in Patients with Multiple Sclerosis
Invest. Ophthalmol. Vis. Sci., December 1, 2007; 48(12): 5798 - 5805.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
S. Rasmussen, Y. Wang, P. Kivisakk, R. T. Bronson, M. Meyer, J. Imitola, and S. J. Khoury
Persistent activation of microglia is associated with neuronal dysfunction of callosal projecting pathways and multiple sclerosis-like lesions in relapsing remitting experimental autoimmune encephalomyelitis
Brain, November 1, 2007; 130(11): 2816 - 2829.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
I. Tsunoda, T. Tanaka, Y. Saijoh, and R. S. Fujinami
Targeting Inflammatory Demyelinating Lesions to Sites of Wallerian Degeneration
Am. J. Pathol., November 1, 2007; 171(5): 1563 - 1575.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
D. Centonze, M. Bari, S. Rossi, C. Prosperetti, R. Furlan, F. Fezza, V. De Chiara, L. Battistini, G. Bernardi, S. Bernardini, et al.
The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis
Brain, October 1, 2007; 130(10): 2543 - 2553.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Neuroradiol.Home page
M.C. Gustafsson, O. Dahlqvist, J. Jaworski, P. Lundberg, and A.-M.E. Landtblom
Low Choline Concentrations in Normal-Appearing White Matter of Patients with Multiple Sclerosis and Normal MR Imaging Brain Scans
AJNR Am. J. Neuroradiol., August 1, 2007; 28(7): 1306 - 1312.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
R. Dutta and B. D. Trapp
Pathogenesis of axonal and neuronal damage in multiple sclerosis
Neurology, May 29, 2007; 68(22_suppl_3): S22 - S31.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
M. Inglese, S.-J. Park, G. Johnson, J. S. Babb, L. Miles, H. Jaggi, J. Herbert, and R. I. Grossman
Deep Gray Matter Perfusion in Multiple Sclerosis: Dynamic Susceptibility Contrast Perfusion Magnetic Resonance Imaging at 3 T
Arch Neurol, February 1, 2007; 64(2): 196 - 202.
[Abstract] [Full Text] [PDF]

Home page
 Mult SclerHome page
J H Simon
Brain atrophy in multiple sclerosis: what we know and would like to know
Multiple Sclerosis, November 1, 2006; 12(6): 679 - 687.
[Abstract] [PDF]

Home page
 Mult SclerHome page
C L Martin, B A Phillips, T J Kilpatrick, H Butzkueven, N Tubridy, E McDonald, and M P Galea
Gait and balance impairment in early multiple sclerosis in the absence of clinical disability
Multiple Sclerosis, September 1, 2006; 12(5): 620 - 628.
[Abstract] [PDF]

Home page
 BrainHome page
G. C. DeLuca, K. Williams, N. Evangelou, G. C. Ebers, and M. M. Esiri
The contribution of demyelination to axonal loss in multiple sclerosis
Brain, June 1, 2006; 129(6): 1507 - 1516.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
T. Wang, R. Allie, K. Conant, N. Haughey, J. Turchan-Chelowo, K. Hahn, A. Rosen, J. Steiner, S. Keswani, M. Jones, et al.
Granzyme B mediates neurotoxicity through a G-protein-coupled receptor
FASEB J, June 1, 2006; 20(8): 1209 - 1211.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
H.-J. Kim, A. B. DiBernardo, J. A. Sloane, M. N. Rasband, D. Solomon, B. Kosaras, S. P. Kwak, and T. K. Vartanian
WAVE1 Is Required for Oligodendrocyte Morphogenesis and Normal CNS Myelination
J. Neurosci., May 24, 2006; 26(21): 5849 - 5859.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
Z. Caramanos, S. Narayanan, and D. L. Arnold
1H-MRS quantification of tNA and tCr in patients with multiple sclerosis: a meta-analytic review
Brain, November 1, 2005; 128(11): 2483 - 2506.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
A Petzold, M J Eikelenboom, G Keir, D Grant, R H C Lazeron, C H Polman, B M J Uitdehaag, E J Thompson, and G Giovannoni
Axonal damage accumulates in the progressive phase of multiple sclerosis: three year follow up study
J. Neurol. Neurosurg. Psychiatry, February 1, 2005; 76(2): 206 - 211.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
N. Norgren, P. Sundstrom, A. Svenningsson, L. Rosengren, T. Stigbrand, and M. Gunnarsson
Neurofilament and glial fibrillary acidic protein in multiple sclerosis
Neurology, November 9, 2004; 63(9): 1586 - 1590.
[Abstract] [Full Text] [PDF]

Home page
 Mult SclerHome page
B. D Coombs, A. Best, M. S Brown, D. E Miller, J. Corboy, M. Baier, and J. H Simon
Multiple sclerosis pathology in the normal and abnormal appearing white matter of the corpus callosum by diffusion tensor imaging
Multiple Sclerosis, August 1, 2004; 10(4): 392 - 397.
[Abstract] [PDF]

Home page
 Mult SclerHome page
C. Lucchinetti and W. Bruck
The pathology of primary progressive multiple sclerosis
Multiple Sclerosis, June 1, 2004; 10(1_suppl): S23 - S30.
[Abstract] [PDF]

Home page
 BrainHome page
C. M. Dalton, D. T. Chard, G. R. Davies, K. A. Miszkiel, D. R. Altmann, K. Fernando, G. T. Plant, A. J. Thompson, and D. H. Miller
Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes
Brain, May 1, 2004; 127(5): 1101 - 1107.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
G. C. DeLuca, G. C. Ebers, and M. M. Esiri
Axonal loss in multiple sclerosis: a pathological survey of the corticospinal and sensory tracts
Brain, May 1, 2004; 127(5): 1009 - 1018.
[Abstract] [Full Text] [PDF]

Home page
 Mult SclerHome page
C. Lucchinetti and W. Bruck
The pathology of primary progressive multiple sclerosis
Multiple Sclerosis, May 1, 2004; 10(3_suppl): S23 - S30.
[Abstract] [PDF]

Home page
 JEMHome page
A. Diestel, O. Aktas, D. Hackel, I. Hake, S. Meier, C. S. Raine, R. Nitsch, F. Zipp, and O. Ullrich
Activation of Microglial Poly(ADP-Ribose)-Polymerase-1 by Cholesterol Breakdown Products during Neuroinflammation: a Link between Demyelination and Neuronal Damage
J. Exp. Med., December 1, 2003; 198(11): 1729 - 1740.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
X Lin, C R Tench, B Turner, L D Blumhardt, and C S Constantinescu
Spinal cord atrophy and disability in multiple sclerosis over four years: application of a reproducible automated technique in monitoring disease progression in a cohort of the interferon {beta}-1a (Rebif) treatment trial
J. Neurol. Neurosurg. Psychiatry, August 1, 2003; 74(8): 1090 - 1094.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
J. J. G. Geurts, G. Wolswijk, L. Bo, P. van der Valk, C. H. Polman, D. Troost, and E. Aronica
Altered expression patterns of group I and II metabotropic glutamate receptors in multiple sclerosis
Brain, August 1, 2003; 126(8): 1755 - 1766.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
D. N. Angelov, S. Waibel, O. Guntinas-Lichius, M. Lenzen, W. F. Neiss, T. L. Tomov, E. Yoles, J. Kipnis, H. Schori, A. Reuter, et al.
Therapeutic vaccine for acute and chronic motor neuron diseases: Implications for amyotrophic lateral sclerosis
PNAS, April 15, 2003; 100(8): 4790 - 4795.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
N. De Stefano, P. M. Matthews, M. Filippi, F. Agosta, M. De Luca, M. L. Bartolozzi, L. Guidi, A. Ghezzi, E. Montanari, A. Cifelli, et al.
Evidence of early cortical atrophy in MS: Relevance to white matter changes and disability
Neurology, April 8, 2003; 60(7): 1157 - 1162.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
I. Tsunoda, L.-Q. Kuang, J. E. Libbey, and R. S. Fujinami
Axonal Injury Heralds Virus-Induced Demyelination
Am. J. Pathol., April 1, 2003; 162(4): 1259 - 1269.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
A. Nicot, P. V. Ratnakar, Y. Ron, C.-C. Chen, and S. Elkabes
Regulation of gene expression in experimental autoimmune encephalomyelitis indicates early neuronal dysfunction
Brain, February 1, 2003; 126(2): 398 - 412.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
E. Bergers, J.C.J. Bot, C.J.A. De Groot, C.H. Polman, G.J. Lycklama a Nijeholt, J.A. Castelijns, P. van der Valk, and F. Barkhof
Axonal damage in the spinal cord of MS patients occurs largely independent of T2 MRI lesions
Neurology, December 10, 2002; 59(11): 1766 - 1771.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
R. D. Fields and B. Stevens-Graham
NEUROSCIENCE: New Insights into Neuron-Glia Communication
Science, October 18, 2002; 298(5593): 556 - 562.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
T. Kuhlmann, G. Lingfeld, A. Bitsch, J. Schuchardt, and W. Bruck
Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time
Brain, October 1, 2002; 125(10): 2202 - 2212.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
D. T. Chard, C. M. Griffin, M. A. McLean, P. Kapeller, R. Kapoor, A. J. Thompson, and D. H. Miller
Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis
Brain, October 1, 2002; 125(10): 2342 - 2352.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
A. Petzold, M. J. Eikelenboom, D. Gveric, G. Keir, M. Chapman, R. H. C. Lazeron, M. L. Cuzner, C. H. Polman, B. M. J. Uitdehaag, E. J. Thompson, et al.
Markers for different glial cell responses in multiple sclerosis: clinical and pathological correlations
Brain, July 1, 2002; 125(7): 1462 - 1473.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by AAN Enterprises, Inc.